1-oxo-1,2,3,4-tetrahydroisoquinoline has been researched along with 3,4-dihydro-5-methyl-1(2h)-isoquinolinone in 1 studies
| Studies (1-oxo-1,2,3,4-tetrahydroisoquinoline) | Trials (1-oxo-1,2,3,4-tetrahydroisoquinoline) | Recent Studies (post-2010) (1-oxo-1,2,3,4-tetrahydroisoquinoline) | Studies (3,4-dihydro-5-methyl-1(2h)-isoquinolinone) | Trials (3,4-dihydro-5-methyl-1(2h)-isoquinolinone) | Recent Studies (post-2010) (3,4-dihydro-5-methyl-1(2h)-isoquinolinone) |
|---|---|---|---|---|---|
| 8 | 0 | 5 | 16 | 0 | 2 |
| Protein | Taxonomy | 1-oxo-1,2,3,4-tetrahydroisoquinoline (IC50) | 3,4-dihydro-5-methyl-1(2h)-isoquinolinone (IC50) |
|---|---|---|---|
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 0.2467 | |
| Poly [ADP-ribose] polymerase 1 | Mus musculus (house mouse) | 0.44 | |
| Protein mono-ADP-ribosyltransferase PARP10 | Homo sapiens (human) | 9.1862 | |
| Protein mono-ADP-ribosyltransferase PARP11 | Homo sapiens (human) | 2.119 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, MS; Kirby, IT; Morgan, RK; Rodriguez, K; Vermehren-Schmaedick, A | 1 |
1 other study(ies) available for 1-oxo-1,2,3,4-tetrahydroisoquinoline and 3,4-dihydro-5-methyl-1(2h)-isoquinolinone
| Article | Year |
|---|---|
Rational Design of Cell-Active Inhibitors of PARP10.
Topics: | 2019 |